These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 926240)

  • 21. Primary treatment of prostatic carcinoma with estramustine phosphate: preliminary report.
    Nilsson T; Jonsson G
    J Urol; 1976 Feb; 115(2):168-9. PubMed ID: 1249870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral estramustine phosphate (NSC-89199) in the treatment of advanced (stage D) carcinoma of the prostate.
    Mittelman A; Shukla SK; Welvaart K; Murphy GP
    Cancer Chemother Rep; 1975; 59(1):219-23. PubMed ID: 1093669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma.
    Agardh CD; Nilsson-Ehle P; Lundgren R; Gustafson A
    J Urol; 1984 Nov; 132(5):1021-4. PubMed ID: 6492270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estramustine phosphate (Estracyt) in the treatment of prostatic carcinoma.
    Könyves I
    Int Urol Nephrol; 1989; 21(4):393-7. PubMed ID: 2693392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with estramustine phosphate.
    Nilsson T; Wear JB
    Wis Med J; 1976 Nov; 75(11):S121-S123. PubMed ID: 1007313
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral estramustine phosphate. Prolonged therapy for advanced carcinoma of prostate.
    Catane R; Mittelman A; Kaufman J; Murphy GP
    N Y State J Med; 1976 Nov; 76(12):1978-81. PubMed ID: 1069190
    [No Abstract]   [Full Text] [Related]  

  • 28. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical results with estramustine phosphate (NSC-89199): a comparison of the intravenous and oral preparations.
    Nilsson T; JONSSON G
    Cancer Chemother Rep; 1975; 59(1):229-32. PubMed ID: 1093671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Nagel R; Köllin CP
    Br J Urol; 1977 Feb; 49(1):73-9. PubMed ID: 837052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T; Mitsuya H; Honda N; Fukatu H; Aota Y; Shinoda M; Yoshida K; Sobajima T; Ohishi M; Tsumura Y
    Hinyokika Kiyo; 1989 Jan; 35(1):179-85. PubMed ID: 2729015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F; Kisbenedek L
    Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
    Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma follicle-stimulating hormone, luteinizing hormone, and sex hormones in patients with gout.
    Marinello E; Riario-Sforza G; Marcolongo R
    Arthritis Rheum; 1985 Feb; 28(2):127-31. PubMed ID: 3918542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.